News Conference News STS 2020 TAVR Tussle at US Surgery Meeting Threatens to Widen Surgeon-Cardiologist Wedge Yael L. Maxwell January 29, 2020
News Conference News PCR London Valves 2019 Signal of Impaired Sapien XT Durability in Midterm Follow-up Michael O'Riordan November 20, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2019 Todd Neale October 31, 2019
News Conference News TCT 2019 Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences L.A. McKeown October 09, 2019
News Daily News PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’ Shelley Wood October 08, 2019
News Conference News TCT 2019 Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR Todd Neale September 29, 2019
Presentation TCT 2019 PARTNER 2A: 5-Year Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis Presenter: Vinod Thourani September 28, 2019
News Opinion Editor's Corner TCT 2019 TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL Shelley Wood September 28, 2019
News Opinion Editor's Corner TCT 2019 TCT 2019 Day Two: Transcatheter Valves, New and Old Shelley Wood September 27, 2019
News Conference News TCT 2019 TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More Shelley Wood September 19, 2019
News Opinion Fellow Talk What I Am Most Looking Forward to at TCT 2019 Mahesh V. Madhavan, MD September 18, 2019
News Daily News Aortic Stenosis Staging System Validated in Real-World, All-Comers Cohort L.A. McKeown February 14, 2019
News Conference News PCR London Valves 2018 Ten-Year Trends in the UK Show TAVR Rates Rising but SAVR Holding Steady Shelley Wood September 11, 2018
News Daily News Low Rate of Bailout Emergency Surgery During TAVR, but Caution Still Needed Michael O'Riordan January 10, 2018
News Opinion Editor's Corner TCT 2017 My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self Shelley Wood November 22, 2017
News Conference News TCT 2017 A-fib Signals Worse Prognosis After Aortic Valve Replacement in Intermediate-Risk Patients Todd Neale November 08, 2017
Presentation TCT 2017 TCT 8391: Atrial Fibrillation Is Associated With Increased Mortality in Intermediate-Risk Patients Undergoing TAVR or SAVR - Insights From the PARTNER 2A and PARTNER 2 S3i Trials Presenter: Steven R. Bailey, Patrick W. Serruys, Angelo Biviano, MD November 01, 2017
News Conference News TCT 2017 Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery Yael L. Maxwell October 31, 2017
Presentation TCT 2017 PARTNER 2A and SAPIEN 3 Cost-effectiveness: Cost-effectiveness of TAVR vs SAVR in Intermediate-Risk Patients With Aortic Stenosis Presenter: Patrick W. Serruys, David J. Cohen October 31, 2017
Presentation TCT 2017 Viewpoint #1: PARTNER 2A and SURTAVI are Convincing TAVR is Preferred in ALL (Appropriate) Intermediate-Risk Patients Presenter: Michael J. Reardon October 30, 2017